Lumiracoxib (Compound)

Synonyms:Lumiracoxib, 220991-20-8, Prexige, COX-189, Lumaricoxib, COX 189, COX189, Prexige;COX 189, 2-(2-((2-chloro-6-fluorophenyl)amino)-5-methylphenyl)acetic acid, 2-[2-(2-chloro-6-fluoroanilino)-5-methylphenyl]acetic acid

Pubchem:PUBCHEM:151166

Id:4b59291f-bfef-536f-b082-ea9cf05c179f

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Lumiracoxib's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Lumiracoxib.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Lumiracoxib.

Results found

Linked to

	Label	Description
	BRD-K26901728-001-05-4 Substance (Entity type)	A Substance
	Lumiracoxib negatively regulates RTN2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Lumiracoxib negatively regulates AHNAK Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Lumiracoxib positively regulates IGF1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Lumiracoxib positively regulates AKAP8 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Lumiracoxib indication Degenerative polyarthritis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Lumiracoxib bioactivity Prostaglandin G/H synthase 2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Lumiracoxib positively regulates CEACAM6 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Lumiracoxib positively regulates DPYSL3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Lumiracoxib in similarity relationship with chlorpyrifos Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS

BRD-K26901728-001-05-4

Substance (Entity type)

A Substance

Lumiracoxib negatively regulates RTN2

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

Lumiracoxib negatively regulates AHNAK

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

Lumiracoxib positively regulates IGF1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

Lumiracoxib positively regulates AKAP8

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

Lumiracoxib indication Degenerative polyarthritis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Lumiracoxib bioactivity Prostaglandin G/H synthase 2

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Lumiracoxib positively regulates CEACAM6

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

Lumiracoxib positively regulates DPYSL3

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

Lumiracoxib in similarity relationship with chlorpyrifos

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.